Regeneron announces new U.S. Government agreement to purchase additional doses of REGEN-COV (casirivimab and imdemivab) antibody cocktail

Regeneron Pharmaceuticals

14 September 2021 - New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly 3 million doses.

Regeneron Pharmaceuticals today announced that the U.S. Department of Health and Human Services and the Department of Defense will purchase 1.4 million additional doses of REGEN-COV (casirivimab and imdevimab). 

The government will continue to provide REGEN-COV at no cost to patients.

Read Regeneron Pharmaceuticals press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Supply , COVID-19